HomeURGN • NASDAQ
add
Urogen Pharma Ltd
Previous close
$16.76
Day range
$16.27 - $16.98
Year range
$3.42 - $21.71
Market cap
770.30M USD
Avg Volume
1.24M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 24.22M | 10.83% |
Operating expense | 62.11M | 36.64% |
Net income | -49.94M | -49.51% |
Net profit margin | -206.24 | -34.89% |
Earnings per share | -1.05 | -15.38% |
EBITDA | -41.37M | -60.53% |
Effective tax rate | -2.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 156.95M | -34.89% |
Total assets | 208.72M | -25.95% |
Total liabilities | 302.09M | 20.10% |
Total equity | -93.38M | — |
Shares outstanding | 46.26M | — |
Price to book | -8.30 | — |
Return on assets | -45.41% | — |
Return on capital | -181.79% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -49.94M | -49.51% |
Cash from operations | -39.82M | -67.70% |
Cash from investing | 28.41M | 136.76% |
Cash from financing | 296.00K | -99.70% |
Net change in cash | -11.12M | -112.56% |
Free cash flow | -18.51M | -55.80% |
About
Founded
2004
Headquarters
Website
Employees
253
